Note for Wholesalers and Parallel Distributors of Avastin and Herceptin of French Origin – Suspected Illegal Export
The Paul-Ehrlich-Institut (PEI) has indicated that those medicinal products Avastin and Herceptin which are of French origin be classified as illegal with a high probability, if exported from France and marketed/sold on other European markets.
Issue 4/2018 of the Pharmacovigilance Bulletin is online
The current Pharmacovigilance Bulletin reports on the world-wide call for reporting suspected cases of adverse effects, and on the new online portal, which has been optimised for patients and their relatives. Other topics include the risk of aorta aneurysms and dissections by fluoroquinolones, and KidSafe – improved provision of medicines to children and adolescents.
Regulation of animal vaccines - safety, efficacy, and availability in the focus
Experts from the Division Veterinary Medicine of the Paul-Ehrlich-Institut (PEI), Federal Institute for Vaccines and Biomedicines met the Working Group "Combating Animal Diseases and Protective Immunisation" of the Federal Association for Animal Health (Bundesverband für Tiergesundheit e.V., BfT) for this year’s dialogue on various aspects of regulation and research of veterinary vaccines.